Table 1.
Preoperative Data
| Preoperative Variables | All Patients, n=168 |
|---|---|
| Age, y (mean±SD) | 68.5±10.2 |
| Female sex, n (%) | 60 (35.7) |
| Cardiac risk factors, n (%) | |
| Diabetes mellitus | 54 (32.1) |
| Systemic hypertension | 158 (94.0) |
| Hyperlipidemia | 104 (61.9) |
| Smoker | 56 (33.3) |
| Comorbidities | |
| Chronic obstructive pulmonary disease, n (%) | 12 (7.0) |
| Stroke, n (%) | 15 (8.9) |
| Peripheral vascular disease, n (%) | 30 (17.9) |
| Glomerular filtration rate, mL/min per 1.73 m2 (mean±SD) | 71±37 |
| Cardiac parameters | |
| Previous myocardial infarction (>90 d), n (%) | 31 (18.5) |
| Left ventricular ejection fraction, % | 52±16 |
| Triple vessel disease, n (%) | 74 (44.0) |
| Left main disease, n (%) | 31 (18.4) |
| Primary indication for PCI or coronary angiography, n (%) | |
| Stable angina pectoris | 98 (58.3) |
| Acute coronary syndrome | 62 (36.9) |
| Asymptomatic at time of coronary angiography | 8 (4.8) |
| Site of intervention, n (%) | |
| In hospital | 133 (79.2) |
| Referral center | 35 (20.8) |
| Clinical and hemodynamic status following PCI complications, n (%) | |
| Myocardial infarction after PCI complication | 112 (66.7) |
| ST‐segment–elevation myocardial infarction | 87 (51.8) |
| Non–ST‐segment–elevation myocardial infarction | 25 (14.9) |
| Cardiac tamponade | 26 (15.5) |
| Inotropic support | 114 (67.8) |
| High dose of inotropic support | 65 (38.7) |
| Critical preoperative state | 96 (57.1) |
| Resuscitation | 34 (20.2) |
| Ventilation | 26 (15.6) |
| Cardiogenic shock | 78 (46.4) |
| Lactate level, mmols/L (mean±SD) | 3.3±4.1 |
| ECMO implantation | 6 (3.5) |
| IABP implantation | 19 (11.3) |
| Time interval from PCI to surgery, min (mean±SD) | 167±107 |
ECMO indicates extracorporeal oxygenation; IABP, intra‐aortic balloon pump implantation; PCI, percutaneous coronary implantation.